Status:
COMPLETED
Fosrenol Post-marketing Surveillance for Hemodialysis in Japan
Lead Sponsor:
Bayer
Conditions:
Hyperphosphatemia
Eligibility:
All Genders
Brief Summary
This study is a regulatory post marketing surveillance in Japan, and it is a local prospective and observational study of patients in hemodialysis who received Fosrenol for hyperphosphatemia. The obje...
Eligibility Criteria
Inclusion
- Patients undergoing hemodialysis who received Fosrenol for hyperphosphatemia
Exclusion
- Patients who are contraindicated based on the product label
Key Trial Info
Start Date :
March 23 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 28 2019
Estimated Enrollment :
3267 Patients enrolled
Trial Details
Trial ID
NCT01419327
Start Date
March 23 2009
End Date
May 28 2019
Last Update
May 20 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Multiple Locations, Japan